SCM

Sarissa Capital Management Portfolio holdings

AUM $154M
This Quarter Return
+19.27%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$1.26B
AUM Growth
+$1.26B
Cap. Flow
+$42.7M
Cap. Flow %
3.4%
Top 10 Hldgs %
99.85%
Holding
14
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

1
ALKS icon
Alkermes
ALKS
$96.1M

Top Sells

1
BCRX icon
BioCryst Pharmaceuticals
BCRX
$53.4M

Sector Composition

1 Healthcare 99.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALKS icon
1
Alkermes
ALKS
$4.78B
$291M 23.14% 11,870,000 +3,920,000 +49% +$96.1M
BIIB icon
2
Biogen
BIIB
$19.4B
$223M 17.7% 643,000 – –
IRWD icon
3
Ironwood Pharmaceuticals
IRWD
$214M
$211M 16.77% 16,390,000 – –
GILD icon
4
Gilead Sciences
GILD
$140B
$186M 14.77% 2,697,400 – –
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$119M 9.5% 650,440 – –
INVA icon
6
Innoviva
INVA
$1.29B
$86M 6.84% 6,414,000 – –
BCRX icon
7
BioCryst Pharmaceuticals
BCRX
$1.74B
$67.4M 5.36% 4,261,000 -3,376,700 -44% -$53.4M
MRSN icon
8
Mersana Therapeutics
MRSN
$36.5M
$54.4M 4.33% 4,005,600 – –
VOR icon
9
Vor Biopharma
VOR
$250M
$13.2M 1.05% 707,010 – –
SRSAW
10
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
$5M 0.4% 3,333,333 – –
RGLS
11
DELISTED
Regulus Therapeutics
RGLS
$1.51M 0.12% 1,851,851 – –
JAZZ icon
12
Jazz Pharmaceuticals
JAZZ
$7.75B
$177K 0.01% 1,000 – –
MRTX
13
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$161K 0.01% 1,000 – –
ICPT
14
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$18K ﹤0.01% 950 – –